含抗氧化剂的培养液改善高龄患者种植前胚胎发育及临床结局
前瞻性随机单中心研究,将127个治疗周期的卵丘-卵母细胞复合体和精液样本均分至含抗氧化剂培养液组与不含抗氧化剂培养液组,主要终点为每成熟卵母细胞的优质囊胚率。结果显示受精率和第5-6天囊胚率显著优于研究组,但优质囊胚率无显著差异;亚组分析显示35-40岁患者在研究组中第3天胚胎发育率、第5-6天囊胚率、优质囊胚率和囊胚利用率显著改善,<35岁患者影响较小。结论认为35-40岁患者全程使用含抗氧化剂培养液可显著改善胚胎发育和单囊胚移植结局。
要点
- 含抗氧化剂培养液组受精率和第5-6天囊胚率显著优于对照组,优质囊胚率无显著差异。
- 35-40岁患者使用含抗氧化剂培养液后第3天胚胎发育率、囊胚率、优质囊胚率和囊胚利用率显著改善。
- 35-40岁患者研究组单囊胚移植的种植率、胎心率和活产率更优,<35岁患者两组无显著差异。
核心结论
- 35-40岁患者全程使用含抗氧化剂培养液可显著改善胚胎发育和单囊胚移植结局。
研究设计与样本
- 前瞻性随机单中心研究,127个治疗周期的卵丘-卵母细胞复合体和精液样本均分至含抗氧化剂培养液组和不含抗氧化剂培养液组。
- 主要终点为每成熟卵母细胞的第5-6天优质囊胚率。
主要发现
- 受精率和每成熟卵母细胞第5-6天囊胚率显著优于研究组,优质囊胚率无显著差异。
- 35-40岁患者研究组第3天胚胎发育率、第5-6天囊胚率、优质囊胚率和囊胚利用率显著改善,<35岁患者影响较小。
- 每臂94例单囊胚移植,35-40岁患者研究组种植率、胎心率和活产率更优,全部年龄和<35岁患者两组无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What are the clinical effects of using culture media supplemented with antioxidants (AOX) throughout the IVF process? DESIGN: Prospective randomized single-centre study. Cumulus-oocyte complexes and semen samples collected from 127 treatment cycles were divided evenly between the study arm (culture media with AOX) and the control arm (culture media without AOX). The primary endpoint was the good-quality blastocyst (GQB) rate on day 5-6 per metaphase II (MII) oocyte. RESULTS: Fertilization rate and day 5-6 blastocyst rate per MII oocyte differed significantly in favour of the study arm, whereas GQB rate did not. A subgroup analysis, stratified by maternal age, revealed significant improvements in the study arm for day 3 embryo development rate, day 5-6 blastocyst rate, GQB rate and blastocyst utilization rate for patients aged 35-40 years, while the impacts on these endpoints were much smaller in patients aged <35 years. Ninety-four single vitrified blastocyst transfers (SVBT) were performed in each arm. The blastocysts derived from the study arm showed better results of SVBT for patients aged 35-40 years, defined by embryo implantation rate, fetal heartbeat rate and live birth rate, whereas these variables did not differ significantly between the two arms when assessing the results for patients of all ages and patients aged <35 years. CONCLUSIONS: Embryo development and SVBT outcomes of treatment cycles of patients aged 35-40 years improved significantly when using AOX-supplemented culture media throughout the IVF process.
引用
- Mizumoto S, Nagao Y, Watanabe H, et al. Culture media with antioxidants improved preimplantation embryo development and clinical outcomes of patients of advanced age. Reprod Biomed Online. 2024. PMID: 39673903. doi:10.1016/j.rbmo.2024.104415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。